Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 308
Selected: 0
NCT IDTitle
NCT01566240Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
NCT02308072Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer
NCT05574738A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT03728881Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial
NCT00801736ERCC1 Targeted Trial
NCT01556841The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer
NCT03212157GlucoCEST MRI in Oncology
NCT05038657Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
NCT01608165A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm)
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
NCT00275132Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT05554523How Does Skin Tone Affect Quantitative Photoacoustic Imaging
NCT00900289Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT01993979A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
NCT00595777Edinburgh Pain Assessment Tool (EPAT©) Study
NCT02042768Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT01431664AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
NCT05848765Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
NCT05272709TT-702 in Patients With Advanced Solid Tumours.
NCT01941849Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma
NCT00072462Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
NCT04178889Second Primary Lung Cancer Cohort Study (SPORT)
NCT00674557Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
NCT00555386Soy, Selenium and Breast Cancer Risk
NCT00450203Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT0010489717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
NCT01926236Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
NCT00720447Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
NCT00002476Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT01685190A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer
NCT03994653Cancer Loyalty Card Study
NCT00003969Geldanamycin Analogue in Treating Patients With Advanced Cancer
NCT03004755The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study
NCT00080912Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
NCT04065269ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss
NCT03415854Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
NCT00006476Suramin in Treating Patients With Recurrent Bladder Cancer
NCT01460888Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
NCT00509561Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
NCT01196715Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
NCT02960620Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT00427713Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
NCT04161417Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer
NCT00337246Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
NCT05770102DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT05368298SCOOT: Sample Collection for DART
NCT04908111A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1